3-123448117-AGCCGCCGCCGCCGAGCCGCC-AGCC
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000462833.6(ADCY5):βc.412_428delβ(p.Gly138CysfsTer184) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000316 in 948,280 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.0 ( 0 hom., cov: 32)
Exomes π: 0.0000032 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ADCY5
ENST00000462833.6 frameshift
ENST00000462833.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.90
Genes affected
ADCY5 (HGNC:236): (adenylate cyclase 5) This gene encodes a member of the membrane-bound adenylyl cyclase enzymes. Adenylyl cyclases mediate G protein-coupled receptor signaling through the synthesis of the second messenger cAMP. Activity of the encoded protein is stimulated by the Gs alpha subunit of G protein-coupled receptors and is inhibited by protein kinase A, calcium and Gi alpha subunits. Single nucleotide polymorphisms in this gene may be associated with low birth weight and type 2 diabetes. Alternatively spliced transcript variants that encode different isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-123448117-AGCCGCCGCCGCCGAGCC-A is Pathogenic according to our data. Variant chr3-123448117-AGCCGCCGCCGCCGAGCC-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 817996.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADCY5 | NM_183357.3 | c.412_428del | p.Gly138CysfsTer184 | frameshift_variant | 1/21 | ENST00000462833.6 | NP_899200.1 | |
ADCY5 | NM_001378259.1 | c.412_428del | p.Gly138CysfsTer184 | frameshift_variant | 1/22 | NP_001365188.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADCY5 | ENST00000462833.6 | c.412_428del | p.Gly138CysfsTer184 | frameshift_variant | 1/21 | 1 | NM_183357.3 | ENSP00000419361 | P1 | |
ADCY5 | ENST00000699718.1 | c.412_428del | p.Gly138CysfsTer184 | frameshift_variant | 1/22 | ENSP00000514543 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 146220Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
146220
Hom.:
Cov.:
32
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000316 AC: 3AN: 948280Hom.: 0 AF XY: 0.00000444 AC XY: 2AN XY: 449958
GnomAD4 exome
AF:
AC:
3
AN:
948280
Hom.:
AF XY:
AC XY:
2
AN XY:
449958
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 146220Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 71126
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
146220
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
71126
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 24, 2019 | The c.412_428del17 variant in the ADCY5 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant causes a frameshift starting with codon Glycine 138, changes this amino acid to a Cysteine residue, and creates a premature Stop codon at position 184 of the new reading frame, denoted p.Gly138CysfsX184. The c.412_428del17 variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. This variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.412_428del17 as a likely pathogenic variant. - |
Neurodevelopmental disorder with hyperkinetic movements and dyskinesia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Breakthrough Genomics, Breakthrough Genomics | Sep 29, 2022 | This variant has not been reported in literature. However, truncating variants lying in the downstream of the identified variants have been reported as pathogenic in the context of dyskinesia with orofacial involvement, autosomal dominant/recessive in the ClinVar database. Loss-of-function variants in the ADCY5 gene are known to be pathogenic [PMID: 28971144, 34631954]. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at